Join
Live feed
·
NEWSReleasevia Quantisnow
Neovasc Inc. logo

The German Institute For Hospital Remuneration System Has Awarded The Neovasc's Reducer, A Ce-marked Medical Device For Refractory Angina, Nub Status 1 Designation For 2023.

ByQuantisnow·Wall Street's wire, on your screen.
NVCN· Neovasc Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVCN (Neovasc Inc.) and more on Quantisnow.

The German Institute For Hospital Remuneration System Has Awarded The Neovasc's Reducer, A Ce-marked Medical Device For Refractory Angina, Nub Status 1 Designation For 2023. | Quantisnow